All Vaccinology articles – Page 7
-
NewsRSV vaccination in older adults with health conditions is cost-effective
Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a cost-effective way to reduce disease, according to a new modelling study.
-
NewsStudy uncovers the specialized immune cells that fight COVID-19
A team of researchers from Osaka University has pinpointed the B cells responsible for boosting COVID-19 immunity after vaccination.
-
NewsNew study provides insight to why Covid vaccines hit some harder than others
Scientists have highlighted factors that may explain why some people perceived more side effects from the SARS-CoV2 vaccine than others, including stress, exercise, and use of hormonal birth control.
-
NewsFirst phase of polio campaign concludes successfully in Gaza
More than 187,000 children under ten years of age were vaccinated with novel oral polio vaccine type 2 (nOPV2) in central Gaza during the first phase of a two-round polio vaccination campaign, conducted between 1–3 September 2024.
-
NewsInvestigational mpox mRNA vaccine reduces disease severity in primates compared to available vaccines
A new mpox vaccine candidate more effectively limits symptoms and disease duration in primates that were infected with a lethal strain of the mpox virus when compared to a currently licensed modified vaccinia Ankara (MVA) vaccine.
-
NewsH5 influenza vaccines: what needs to be done to reduce the risk of a pandemic
As the global threat of H5N1 influenza looms, three international vaccine and public health experts say it is time to fully resource and support a robust strategy to address this and future potential pandemic influenza threats.
-
NewsCOVID-19 vaccination mandates boosted uptake among health care workers
A new study has found that state-level COVID-19 vaccination mandates successfully increased vaccine rates among health care workers, providing evidence that the policy can boost rates even in a highly vaccinated, highly educated population.
-
NewsGut bacteria composition influences rotavirus vaccine efficacy
Gut microbiota can influence rotavirus vaccine responsiveness and sometimes result in children remaining prone to rotavirus infection and severe disease despite having been vaccinated.
-
NewsWHO: Cholera surges as response efforts hit by critical shortage of Oral Cholera Vaccines
Since the start of the year, more than 300,000 cases of cholera and 2,326 deaths have been recorded worldwide, as the World Health Organization warns of a critical shortage of oral vaccines.
-
NewsNew vaccine against cervical cancer combines prophylactic and therapeutic activity
Scientists at the German Cancer Research Center (DKFZ) have developed a completely new vaccination concept with a new vaccine against cancer-causing human papillomaviruses (HPV).
-
NewsWHO declares mpox outbreak a public health emergency of international concern
WHO Director-General Dr Tedros Adhanom Ghebreyesus has declared that the upsurge of mpox in the Democratic Republic of the Congo and a growing number of countries in Africa constitutes a public health emergency of international concern.
-
NewsFirst-of-its-kind vaccine expands malaria protection for pregnant women
For the first time, immunization with a malaria vaccine has been shown to protect mothers from malaria during pregnancy and to protect for two transmission seasons without booster doses of vaccine.
-
NewsStudy finds shingles increased risk of subsequent cognitive decline
A new study has found that an episode of shingles is associated with about a 20 per cent higher long-term risk of subjective cognitive decline, providing support for getting the shingles vaccine to decrease risk of developing shingles.
-
NewsNanoparticle platform offers step toward more effective Covid and HIV vaccines
Researchers have developed a nanoparticle platform that could make existing vaccines more effective, including those for influenza, COVID-19, and HIV.
-
NewsDengue vaccine is effective and safe, reveals first global meta-analysis
The study, conducted by cross-referencing data from 19 scientific studies, involving over 20,000 individuals, shows an efficacy rate of over 50% in reducing disease cases, with lasting effects and a high safety profile.
-
NewsNew two-step flu vaccine strategy shows promise in pig model
A new, two-step flu vaccination strategy that pairs intramuscular injection of a viral vectored flu vaccine with nasal spray administration of a novel attenuated live flu virus appears to be safe and effective in pigs.
-
NewsPrioritizing the elderly for COVID-19 boosters reduces overall deaths
When COVID-19 booster vaccines are in short supply, prioritizing the elderly over other age groups for booster vaccination results in the lowest loss of life, reports a new study.
-
NewsAmid Covid-19 summer wave, new WHO/Europe study confirms the lifesaving impact of vaccines
From the time of their introduction in December 2020 through to March 2023, COVID-19 vaccines reduced deaths due to the pandemic by at least 59%, saving more than 1.6 million lives in the WHO European Region.
-
NewsWHO pays tribute to polio-eradication leader Aidan O’Leary
The Director-General General of the World Health Organization has led tributes following the sudden death of Aidan O’Leary, who was leading global efforts to eradicate polio. Geneva-based Aidan O’Leary, the director of the WHO’s Polio Eradication Programme since 2021, died suddenly while on a family holiday on ...
-
NewsResearchers create new treatment and vaccine for flu and various coronaviruses
A team of researchers has discovered two new ways of preventing and treating respiratory viruses using nasal sprays.